Obesity Companies Prolong The Inevitable As Cash Runs Out

Arena and Vivus both announce efforts to conserve cash and they struggle with virtually nonexistent sales of their obesity drugs. Neither company has laid out plans for next steps.

More from Business

More from Scrip